16-88653337-G-A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_002461.3(MVD):​c.1085C>T​(p.Pro362Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000156 in 1,600,368 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00016 ( 2 hom. )

Consequence

MVD
NM_002461.3 missense

Scores

4
15

Clinical Significance

Uncertain significance no assertion criteria provided U:1

Conservation

PhyloP100: 3.37

Publications

3 publications found
Variant links:
Genes affected
MVD (HGNC:7529): (mevalonate diphosphate decarboxylase) The enzyme mevalonate pyrophosphate decarboxylase catalyzes the conversion of mevalonate pyrophosphate into isopentenyl pyrophosphate in one of the early steps in cholesterol biosynthesis. It decarboxylates and dehydrates its substrate while hydrolyzing ATP. [provided by RefSeq, Jul 2008]
MVD Gene-Disease associations (from GenCC):
  • porokeratosis 7, multiple types
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • disseminated superficial actinic porokeratosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0069036186).
BS2
High AC in GnomAd4 at 20 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MVDNM_002461.3 linkc.1085C>T p.Pro362Leu missense_variant Exon 9 of 10 ENST00000301012.8 NP_002452.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MVDENST00000301012.8 linkc.1085C>T p.Pro362Leu missense_variant Exon 9 of 10 1 NM_002461.3 ENSP00000301012.3 P53602
MVDENST00000565149.5 linkn.1644C>T non_coding_transcript_exon_variant Exon 5 of 6 1
MVDENST00000561895.1 linkn.366C>T non_coding_transcript_exon_variant Exon 2 of 3 2
MVDENST00000562981.1 linkn.248C>T non_coding_transcript_exon_variant Exon 1 of 2 2

Frequencies

GnomAD3 genomes
AF:
0.000131
AC:
20
AN:
152192
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00432
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000290
AC:
68
AN:
234806
AF XY:
0.000335
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00602
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000836
Gnomad OTH exome
AF:
0.000353
GnomAD4 exome
AF:
0.000159
AC:
230
AN:
1448176
Hom.:
2
Cov.:
32
AF XY:
0.000190
AC XY:
137
AN XY:
720748
show subpopulations
African (AFR)
AF:
0.0000618
AC:
2
AN:
32350
American (AMR)
AF:
0.0000750
AC:
3
AN:
40024
Ashkenazi Jewish (ASJ)
AF:
0.00614
AC:
157
AN:
25556
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39450
South Asian (SAS)
AF:
0.0000237
AC:
2
AN:
84524
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52196
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5718
European-Non Finnish (NFE)
AF:
0.0000361
AC:
40
AN:
1108522
Other (OTH)
AF:
0.000435
AC:
26
AN:
59836
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
12
24
37
49
61
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000131
AC:
20
AN:
152192
Hom.:
0
Cov.:
34
AF XY:
0.000148
AC XY:
11
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41440
American (AMR)
AF:
0.0000654
AC:
1
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00432
AC:
15
AN:
3472
East Asian (EAS)
AF:
0.000192
AC:
1
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68024
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000510
Hom.:
0
Bravo
AF:
0.000185
ExAC
AF:
0.000223
AC:
27

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

not provided Uncertain:1
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The MVD p.Pro362Leu variant was not identified in the literature nor was it identified in ClinVar. The variant was identified in dbSNP (ID: rs201844867) and in control databases in 71 of 266178 chromosomes at a frequency of 0.0002667 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: Ashkenazi Jewish in 57 of 9592 chromosomes (freq: 0.005942), Other in 2 of 6750 chromosomes (freq: 0.000296), European (non-Finnish) in 10 of 123014 chromosomes (freq: 0.000081), East Asian in 1 of 18628 chromosomes (freq: 0.000054) and South Asian in 1 of 28614 chromosomes (freq: 0.000035), but was not observed in the African, Latino, or European (Finnish) populations. The p.Pro362 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.45
CADD
Uncertain
24
DANN
Benign
0.72
DEOGEN2
Benign
0.42
T
Eigen
Benign
-0.38
Eigen_PC
Benign
-0.32
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.73
T
M_CAP
Benign
0.028
D
MetaRNN
Benign
0.0069
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
3.4
PrimateAI
Uncertain
0.56
T
PROVEAN
Uncertain
-4.1
D
REVEL
Benign
0.10
Sift
Benign
0.65
T
Sift4G
Benign
0.47
T
Polyphen
0.066
B
Vest4
0.38
MVP
0.17
MPC
0.057
ClinPred
0.089
T
GERP RS
3.2
RBP_binding_hub_radar
0.97
RBP_regulation_power_radar
2.7
Varity_R
0.28
gMVP
0.59
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201844867; hg19: chr16-88719745; COSMIC: COSV55368399; COSMIC: COSV55368399; API